Study provides scaffold to selectively target drug breakdown process (IMAGE)

St. Jude Children's Research Hospital

Study provides scaffold to selectively target drug breakdown process

Caption

Published today in Nature Communications, a panel of CYP3A4 inhibitors from the lab of Taosheng Chen, PhD, PMP, St. Jude Department of Chemical Biology & Therapeutics, lays the groundwork for selective cytochrome P450 inhibition.

Credit

St. Jude Children's Research Hospital

Usage Restrictions

No cropping

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.